Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial
Pål Aukrust, Péter Szodoray, Marte Glambek, Bjørn‐Eivind Kirsebom et al.
Journal
Trials
Topics
COVID-19 Clinical Research Studies
article
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial
Pål Aukrust, Péter Szodoray, Marte Glambek, Bjørn‐Eivind Kirsebom, Bjørn Blomberg, Camilla Tøndel, Arild Iversen, Vibeke Devold Valderhaug, Maja Wilhelmsen, Axel Sandvig, Rolv T. Lie, Rebecca Jane Cox, Martin Lehmann, Oddvar Kaarbøe, Oddvar Oppegaard, Tuva Børresdatter Dahl, Nina Langeland, Nikolai Norevik Myklebust
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Oslo University Hospital (NO), University Hospital of North Norway (NO), University of Oslo (NO), Norwegian University of Science and Technology (NO), Haukeland University Hospital (NO), Ålesund Hospital (NO), St Olav's University Hospital (NO), Bergen Kommune (NO), University of Bergen (NO), UiT The Arctic University of Norway (NO)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Randomized trial of nirmatrelvir/ritonavir versus placebo for adults with acute COVID-19 to prevent long COVID: PanoramicNOR Trial — Pål Aukrust, Péter Szodoray, et al. · Trials (2025) | TGRS Research Map | TGRS